Follow the Assertio Holdings, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Assertio Holdings, Inc. has recorded 130 reports. Market capitalisation: €151.9m. The latest transaction was filed on 16 June 2026 (U). Among the most active insiders: Patel Ajay. The full history is openly available.
130
Insider Decl.
n/a
Thresholds
€141,353
7 ops.
Buy Volume
€2m
13 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Assertio Holdings, Inc. Buy (bullish), based on 3 analysts. Average price target: US$24.43.
36Σ signal
Buys €141,353€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,910 of 28,685 companies
17.3
score / 100
Value
8
Quality
27
FCF yld-19%
Earn yld-20%
EV/EBITDA50.1x
ROE-39%
Gross mgn70%
Net mgn-26%
Debt/EBITDA10.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
8,959 shares@ US$0.7597100.0% of flowCommon StockSEC:0001104659-25-110557:0
25 of 130 declarations
About Assertio Holdings, Inc.
Assertio Holdings, Inc. is a company focused on the development and commercialization of pharmaceutical products. It is listed on the NASDAQ under the ticker ASRT.